Kolliphor EL: Difference between revisions
Content deleted Content added
Esploranto (talk | contribs) Remove URL tracking parameters |
|||
| (15 intermediate revisions by 11 users not shown) | |||
| Line 1: | Line 1: | ||
{{short description|Brand name for polyethoxylated castor oil}} |
|||
'''Kolliphor EL''', formerly known as '''Cremophor EL''', is the registered trademark of [[BASF]] Corp. for its version of polyethoxylated castor oil. It is prepared by reacting 35 moles of [[ethylene oxide]] with each mole of [[castor oil]]. The resulting product is a mixture ([[CAS registry number|CAS number]] 61791-12-6): the major component is the material in which the hydroxyl groups of the castor oil [[triglyceride]] have [[ethoxylation|ethoxylated]] with ethylene oxide to form [[polyethylene glycol]] [[ethers]]. Minor components are the polyethyelene glycol [[esters]] of [[ricinoleic acid]], |
'''Kolliphor EL''', formerly known as '''Cremophor EL''', is the registered trademark of [[BASF]] Corp. for its version of polyethoxylated castor oil. It is prepared by reacting 35 moles of [[ethylene oxide]] with each mole of [[castor oil]]. The resulting product is a mixture ([[CAS registry number|CAS number]] 61791-12-6): the major component is the material in which the hydroxyl groups of the castor oil [[triglyceride]] have been [[ethoxylation|ethoxylated]] with ethylene oxide to form [[polyethylene glycol]] [[ethers]]. Minor components are the polyethyelene glycol [[esters]] of [[ricinoleic acid]], polyethylene glycols and polyethylene glycol ethers of [[glycerol]].<ref>{{cite web |title=Kolliphor EL |url=https://pharma.basf.com/products/kolliphor-el |accessdate=2010-12-16}}</ref> Kolliphor EL is a synthetic, [[nonionic]] [[surfactant]] used to stabilize [[emulsions]] of nonpolar materials in [[water]]. |
||
Kolliphor EL is an [[excipient]] or additive in drugs. Therapeutically, modern drugs are rarely given in a pure chemical state, so most active ingredients are combined with excipients or additives such as Kolliphor EL.<ref>{{cite |
Kolliphor EL is an [[excipient]] or additive in drugs. Therapeutically, modern drugs are rarely given in a pure chemical state, so most active ingredients are combined with excipients or additives such as Kolliphor EL.<ref>{{cite journal|pmid=4148526 |year=1973 |last1=Clarke |first1=R. S. |last2=Dundee |first2=J. W. |last3=Carson |first3=I. W. |title=New Drugs in Anæsthesia: A New Steroid Anaesthetic-Althesin |journal=Proceedings of the Royal Society of Medicine |volume=66 |issue=10 |pages=1027–1030 |doi=10.1177/003591577306601023 |pmc=1645602 }} See page 1/49, Methods and Materials.</ref> |
||
==Uses== |
==Uses== |
||
* [[Miconazole]], anti-fungal{{Citation needed|date=July 2018}} |
* [[Miconazole]], anti-fungal{{Citation needed|date=July 2018}} |
||
* |
* Paclitaxel (Taxol), anti-cancer{{Citation needed|date=July 2018}} |
||
* Aci-Jel (acetic acid / oxyquinoline / ricinoleic acid - vaginal){{Citation needed|date=July 2018}} |
* Aci-Jel (acetic acid / oxyquinoline / ricinoleic acid - vaginal){{Citation needed|date=July 2018}} |
||
* [[Sandimmune]] (cyclosporine injection, USP){{Citation needed|date=July 2018}} |
* [[Sandimmune]] (cyclosporine injection, USP){{Citation needed|date=July 2018}} |
||
* [[Nelfinavir mesylate]], [[HIV]] protease inhibitor{{Citation needed|date=July 2018}} |
* [[Nelfinavir mesylate]], [[HIV]] protease inhibitor{{Citation needed|date=July 2018}} |
||
* [[Propofol]], intravenous anaesthetic agent, originally |
* [[Propofol]], intravenous anaesthetic agent, originally solublized with Cremophor EL in trials; later approved with a lipid emulsion{{Citation needed|date=April 2023}} |
||
* [[Diazepam]] injection; superseded by lipid emulsion alternative (Diazemuls){{Citation needed|date=July 2018}} |
* [[Diazepam]] injection; superseded by lipid emulsion alternative (Diazemuls){{Citation needed|date=July 2018}} |
||
* [[Vitamin K]] injection{{Citation needed|date=July 2018}} |
* [[Vitamin K]] injection{{Citation needed|date=July 2018}} |
||
| Line 17: | Line 18: | ||
Allergic reactions to [[Taxol]] are most often allergic reactions to Kolliphor EL; symptoms include tightness in the chest, shortness of breath, and similar reactions consistent with severe anaphylactic reactions. Although many anti-allergens including corticosteroids and Benadryl may be administered before chemotherapy, they are not always sufficient to prevent the severe reaction to Kolliphor EL. |
Allergic reactions to [[Taxol]] are most often allergic reactions to Kolliphor EL; symptoms include tightness in the chest, shortness of breath, and similar reactions consistent with severe anaphylactic reactions. Although many anti-allergens including corticosteroids and Benadryl may be administered before chemotherapy, they are not always sufficient to prevent the severe reaction to Kolliphor EL. |
||
Allergic reaction should not be confused with the normal side effects of [[Taxol]]. The allergic reaction is usually immediate, similar to severe allergic reactions typical of other allergens. |
|||
BASF offers a purified, injectable version of Kolliphor EL, known as Kolliphor ELP.<ref>{{Cite web |title=Kolliphor® ELP |url=https://pharma.basf.com/products/kolliphor-elp |access-date=2022-06-11 |website=BASF Pharma |language=en-US}}</ref> |
|||
==See also== |
==See also== |
||
Latest revision as of 20:47, 3 December 2024
Kolliphor EL, formerly known as Cremophor EL, is the registered trademark of BASF Corp. for its version of polyethoxylated castor oil. It is prepared by reacting 35 moles of ethylene oxide with each mole of castor oil. The resulting product is a mixture (CAS number 61791-12-6): the major component is the material in which the hydroxyl groups of the castor oil triglyceride have been ethoxylated with ethylene oxide to form polyethylene glycol ethers. Minor components are the polyethyelene glycol esters of ricinoleic acid, polyethylene glycols and polyethylene glycol ethers of glycerol.[1] Kolliphor EL is a synthetic, nonionic surfactant used to stabilize emulsions of nonpolar materials in water.
Kolliphor EL is an excipient or additive in drugs. Therapeutically, modern drugs are rarely given in a pure chemical state, so most active ingredients are combined with excipients or additives such as Kolliphor EL.[2]
Uses
[edit]- Miconazole, anti-fungal[citation needed]
- Paclitaxel (Taxol), anti-cancer[citation needed]
- Aci-Jel (acetic acid / oxyquinoline / ricinoleic acid - vaginal)[citation needed]
- Sandimmune (cyclosporine injection, USP)[citation needed]
- Nelfinavir mesylate, HIV protease inhibitor[citation needed]
- Propofol, intravenous anaesthetic agent, originally solublized with Cremophor EL in trials; later approved with a lipid emulsion[citation needed]
- Diazepam injection; superseded by lipid emulsion alternative (Diazemuls)[citation needed]
- Vitamin K injection[citation needed]
- Ixabepilone, anti-cancer[citation needed]
Side effects
[edit]Allergic reactions to Taxol are most often allergic reactions to Kolliphor EL; symptoms include tightness in the chest, shortness of breath, and similar reactions consistent with severe anaphylactic reactions. Although many anti-allergens including corticosteroids and Benadryl may be administered before chemotherapy, they are not always sufficient to prevent the severe reaction to Kolliphor EL.
Allergic reaction should not be confused with the normal side effects of Taxol. The allergic reaction is usually immediate, similar to severe allergic reactions typical of other allergens.
BASF offers a purified, injectable version of Kolliphor EL, known as Kolliphor ELP.[3]
See also
[edit]References
[edit]- ^ "Kolliphor EL". Retrieved 2010-12-16.
- ^ Clarke, R. S.; Dundee, J. W.; Carson, I. W. (1973). "New Drugs in Anæsthesia: A New Steroid Anaesthetic-Althesin". Proceedings of the Royal Society of Medicine. 66 (10): 1027–1030. doi:10.1177/003591577306601023. PMC 1645602. PMID 4148526. See page 1/49, Methods and Materials.
- ^ "Kolliphor® ELP". BASF Pharma. Retrieved 2022-06-11.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |